Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM.

MLA

Khera, Rohan, et al. “Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM.” Journal of the American College of Cardiology, vol. 84, no. 10, Sept. 2024, pp. 904–17. EBSCOhost, https://doi.org/10.1016/j.jacc.2024.05.069.

APA

Khera, R., Aminorroaya, A., Dhingra, L. S., Thangaraj, P. M., Pedroso Camargos, A., Bu, F., Ding, X., Nishimura, A., Anand, T. V., Arshad, F., Blacketer, C., Chai, Y., Chattopadhyay, S., Cook, M., Dorr, D. A., Duarte-Salles, T., DuVall, S. L., Falconer, T., French, T. E., … Suchard, M. A. (2024). Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM. Journal of the American College of Cardiology, 84(10), 904–917. https://doi.org/10.1016/j.jacc.2024.05.069

Chicago

Khera, Rohan, Arya Aminorroaya, Lovedeep Singh Dhingra, Phyllis M Thangaraj, Aline Pedroso Camargos, Fan Bu, Xiyu Ding, et al. 2024. “Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM.” Journal of the American College of Cardiology 84 (10): 904–17. doi:10.1016/j.jacc.2024.05.069.